Inflammatory bowel disease
Classification according to ICD-10 | |
---|---|
K50 - K52 | Non-infectious enteritis and colitis |
ICD-10 online (WHO version 2019) |
Under chronic inflammatory bowel diseases ( IBD ; English inflammatory bowel disease , IBD ) refers to repeating (recurrent) or continuous inflammatory diseases of the intestine . The two most common representatives are ulcerative colitis and Crohn's disease . Collagenic and lymphocytic colitis are less common than forms of microscopic colitis , which can only be diagnosed histologically .
May 19th is World IBD Day .
Typical symptoms and differential diagnosis
Diagnosis | Crohn's disease | Ulcerative colitis |
---|---|---|
Clinic: Bloody stool |
rarely |
often |
Roentgen: Infection of the |
discontinuous, |
continuously |
Colonoscopy: rectum affected |
approx. 50 % |
> 90% |
Pathology: - Macroscopic morphology, |
Paving stone relief (discontinuous, English "skip lesions") |
Fibrosis, pseudopolyps |
Genetic disposition
In 2009, scientists working with Christoph Klein , then head of the Pediatric Clinic at the Hannover Medical School , and Bodo Grimbacher from the Royal Free Hospital in London discovered the first human genetic defect that causes inflammatory bowel disease. Due to a mutation in the two genes of the IL10 receptor ( IL10RA and IL10RB ), the immune cells can no longer receive the modulating signals of the messenger substance interleukin-10 . There are severe inflammatory changes in the intestinal wall with fistula formation and an accumulation of pus . This genetic defect can be permanently remedied by allogeneic stem cell transplantation .
Psychosomatics
It is assumed that in the case of inflammatory bowel diseases, psychosocial stress also leads to a dysregulation of the immune response and - with the appropriate predisposition - to activation of the disease. This stress can lead to re-inflammation in patients. In 1950, Franz Alexander describes inflammatory bowel disease as a psychosomatic illness in the Holy Seven .
literature
- Luca Pastorelli, Carlo De Salvo u. a .: Central Role of the Gut Epithelial Barrier in the Pathogenesis of Chronic Intestinal Inflammation: Lessons Learned from Animal Models and Human Genetics. In: Frontiers in Immunology. 4, 2013, doi: 10.3389 / fimmu.2013.00280 .
- ML Chen, MS Sundrud: Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases. In: Inflammatory bowel diseases. [Electronic publication before going to press] February 2016, doi: 10.1097 / MIB.0000000000000714 , PMID 26863267 .
Individual evidence
- ↑ Baumgart DC, Carding SR: Inflammatory bowel disease: cause and immunobiology. In: The Lancet . tape 369 , no. 9573 , 2007, p. 1627-1640 , doi : 10.1016 / S0140-6736 (07) 60750-8 , PMID 17499605 .
- ↑ DC Baumgart, WJ Sandborn: Inflammatory bowel disease: clinical aspects and established and evolving therapies. In: The Lancet . tape 369 , no. 9573 , 2007, p. 1641–1657 , doi : 10.1016 / S0140-6736 (07) 60751-X , PMID 17499606 .
- ↑ RJ Xavier, DK Podolsky: Unraveling the pathogenesis of inflammatory bowel disease. In: Nature . tape 448 , no. 7152 , 2007, p. 427-434 , doi : 10.1038 / nature06005 , PMID 17653185 .
- ↑ Gerd Herold and colleagues: Internal Medicine 2020. Self-published, Cologne 2020, ISBN 978-3-9814660-9-6 , p. 485.
- ↑ EO Glocker, D. Kotlarz, K. Boztug, EM Gertz, AA Schäffer, F. Noyan, M. Perro, J. Diestelhorst, A. Allroth, D. Murugan, N. Hätscher, D. Pfeifer, KW Sykora, M Sauer, H. Kreipe, M. Lacher, R. Nustede, C. Woellner, U. Baumann, U. Salzer, S. Koletzko, N. Shah, AW Segal, A. Sauerbrey, S. Buderus, SB Snapper, B. Grimbacher, C. Klein: Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. In: N Engl J Med. 361 (21), Nov 19, 2009, pp. 2033-2045. PMID 19890111